Takeda snares approval for all-comer gastric cancer drug

Takeda snares approval for all-comer gastric cancer drug

Submitted by admin on November 12, 2023 - 9:23pm
Source: 
Medical Marketing and Media
News Tags: 
Takeda
Fruzaqla
colorectal cancer
Headline: 
Takeda snares approval for all-comer gastric cancer drug
snippet: 


The Food and Drug Administration greenlit Takeda’s Fruzaqla, a biomarker-agnostic pill for refractory metastatic colorectal cancer (mCRC), the regulator said Wednesday.

Do Not Allow Advertisers to Use My Personal information